Patients With Cardiovascular Disease clinical trials

Explore recruiting patients with cardiovascular disease clinical trials.

Recruiting patients with cardiovascular disease studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Patients With Cardiovascular Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Aspirin in immune thrombocytopenia patients with cardiovascular disease

France

Phase III and phase IV (Integrated) EU CTIS Study details

A randomised, double-blind, three parallel-group, placebo controlled superiority trial assessing the effect of intravenous versus oral iron supplementation on physical performance, quality of life and cognitive function in iron deficient FRAIL elderly IndiviDuals with cardiovascular disease (FRAIL-ID trial)

Poland

Therapeutic use (Phase IV) EU CTIS Study details

A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein (a) lowering with pelacarsen (TQJ230) on major cardiovascular events in patients with established cardiovascular disease

Hungary, Czechia, Sweden, Italy, Netherlands, Germany +14 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A single arm, open label extension (OLE), multicenter study to evaluate long-term safety and tolerability of pelacarsen (TQJ230) in patients with cardiovascular disease who have successfully completed the Frontiers Apheresis parent study

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Patients With Cardiovascular Disease trials by city

Patients With Cardiovascular Disease clinical trials

Recruiting patients with cardiovascular disease studies right now

CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases

Effect of eHealth Cardiac Rehabilitation Incorporating Mindfulness for Patients With Coronary Heart Disease

A Multicenter, Randomized, Open-label, Parallel-group, Controlled, Superiority Phase III Clinical Study Comparing the Efficacy and Safety of F182112 Versus Standard of Care in Patients With Relapsed or Refractory Multiple Myeloma

MRI in Transcatheter Aortic Valve Replacement Patients

Next Generation Sequencing Analysis of Patients with Spontaneous Dissection of Cervical Arteries

High-definition Transcranial Electrical Stimulation for Upper Extremity Rehabilitation

Efficacy of the Adipose Graft Transposition Procedure (AGTP) in Patients With a Myocardial Scar: The AGTP II Trial

LAAO Versus NOAC in Patients with AF and PCI

Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia)

Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes

A Study to Evaluate RO7851624 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma

Also recruiting in Europe

Aspirin in immune thrombocytopenia patients with cardiovascular disease

A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein (a) lowering with pelacarsen (TQJ230) on major cardiovascular events in patients with established cardiovascular disease

A single arm, open label extension (OLE), multicenter study to evaluate long-term safety and tolerability of pelacarsen (TQJ230) in patients with cardiovascular disease who have successfully completed the Frontiers Apheresis parent study

Patients With Cardiovascular Disease trials by city

Other conditions